The VALIDATE Network - Vaccine development for complex intracellular neglected pathogens
TRANSVAC M3 course: Adjuvants and vaccine formulation, 2021
Course dates: 25-28 March 2021
Location: Vaccine Formulation Institute (VFI), Switzerland
Deadline for applications: 1 Nov 2020
TRANSVAC is a collaborative infrastructure project funded by the European Commission (EC), initially under the 7th Framework Programme (FP7) and currently under Horizon 2020. The project is a joint effort of leading European groups working in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC is designed to accelerate vaccine development by enhancing European vaccine research and training, and increase sustainability of EC vaccine projects by implementing a permanent research infrastructure for early vaccine development.
Training scientists in vaccine research and development is crucial in order to sustain Europe’s excellence in this field. The TRANSVAC2 Consortium has set up training modules at leading European centres (in collaboration with WP18 partners) that can be combined to create customised international courses on vaccine R&D. Two rounds of customised training courses are planned. Participants can select topics as needed in their field of vaccine development, and the timelines of the various modules will be harmonised in a way that allows a logical continuation from one topic to the other.
The course provides an overview of State-of-the-art adjuvant systems and addresses the preclinical and clinical development of adjuvanted vaccines.
Participants will be selected by the Course Selection Panel (CSP), according to their educational background, involvement in vaccine research and development as well as the expected impact of the course at personal and institutional level in the context of vaccine development i.e. how the training can be used in their daily work.
Candidates working in a European Union Member State or Associated Member State are eligible to apply. Candidates from another country who are working in vaccine development projects funded by the European Commission (EC) or EDCTP will also be eligible to apply. Other candidates can also apply, but preference will be given to the groups mentioned above.
There is no admission fee for any of the training courses. However, short-listed candidates will have to cover their own travel and visa expenses, and for some courses they have to cover also accommodation costs. For more details please see the relevant training description.
For how to apply, or to find out more about this course, visit the TRANSVAC website.